Meeting
2023 ASCO Annual Meeting
Multimodal machine learning analysis of more than 220,000 tumor profiles to diagnose molecular and morphological subtypes of cancer.
Authors
Jim Abraham
Caris Life Sciences, Phoenix, AZ
Jim Abraham , Sergey Klimov , Eghbal Amidi , Amy B. Heimberger , John Marshall , Elisabeth I. Heath , Joseph J. Drabick , Brian Rubin , Rouba Ali-Fehmi , David R. Braxton , George W. Sledge Jr., David Bryant , Curtis Johnston , Hassan Ghani , Matthew James Oberley , David Spetzler
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Molecular Diagnostics and Imaging
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3078)
DOI
10.1200/JCO.2023.41.16_suppl.3078
Abstract #
3078
Poster Bd #
276
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Breakthrough
A scalable 3D spatial multi-omics method for high-plex morpho-molecular imaging of millimeter-thick tissues.
First Author: Hei Ming Lai
Poster
2024 ASCO Annual Meeting
Effect of combination of genomic variation–based machine learning and clinical pathology on accurate diagnosis of tumors: Lung adenocarcinoma and lung squamous cell carcinoma.
First Author: Weiguang Gu
Poster
2024 ASCO Annual Meeting
Artificial intelligence-based prediction model of malignant lung nodules for preoperative planning.
First Author: Di Lu
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Utility of gene expression–based cancer classification in diagnosis of malignant peritoneal mesothelioma (MPeM): Filling in the gaps in standard pathologic work-up for a rare cancer.
First Author: Joelle Allam